ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 51 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $39,036 | -24.2% | 119,741 | 0.0% | 0.00% | – |
| Q1 2023 | $51,489 | -59.4% | 119,741 | -50.0% | 0.00% | – |
| Q4 2022 | $126,926 | +44.2% | 239,482 | +100.0% | 0.00% | – |
| Q3 2022 | $88,000 | -35.8% | 119,741 | 0.0% | 0.00% | – |
| Q2 2022 | $137,000 | -44.1% | 119,741 | 0.0% | 0.00% | – |
| Q1 2022 | $245,000 | -22.2% | 119,741 | +9.4% | 0.00% | – |
| Q4 2021 | $315,000 | -32.1% | 109,438 | 0.0% | 0.00% | – |
| Q3 2021 | $464,000 | -19.9% | 109,438 | 0.0% | 0.00% | – |
| Q2 2021 | $579,000 | +972.2% | 109,438 | +843.4% | 0.00% | – |
| Q1 2021 | $54,000 | -30.8% | 11,600 | -50.1% | 0.00% | – |
| Q2 2020 | $78,000 | -95.2% | 23,250 | -94.5% | 0.00% | – |
| Q1 2020 | $1,627,000 | -33.3% | 424,725 | +5.2% | 0.00% | – |
| Q4 2019 | $2,438,000 | -16.0% | 403,691 | +5.1% | 0.00% | – |
| Q3 2019 | $2,903,000 | -39.2% | 383,997 | +8.9% | 0.00% | – |
| Q2 2019 | $4,778,000 | +5329.5% | 352,652 | +2071.8% | 0.00% | – |
| Q1 2019 | $88,000 | +79.6% | 16,238 | -0.9% | 0.00% | – |
| Q4 2018 | $49,000 | -64.2% | 16,378 | -3.0% | 0.00% | – |
| Q3 2018 | $137,000 | -22.2% | 16,888 | -5.9% | 0.00% | – |
| Q2 2018 | $176,000 | -88.9% | 17,951 | -90.2% | 0.00% | – |
| Q1 2018 | $1,592,000 | -24.6% | 183,391 | +8.7% | 0.00% | – |
| Q4 2017 | $2,111,000 | +67.9% | 168,683 | +12.1% | 0.00% | – |
| Q3 2017 | $1,257,000 | -53.4% | 150,419 | -5.4% | 0.00% | – |
| Q2 2017 | $2,698,000 | +657.9% | 158,965 | +322.5% | 0.00% | – |
| Q1 2016 | $356,000 | -4.3% | 37,629 | +1.5% | 0.00% | – |
| Q4 2015 | $372,000 | – | 37,067 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |